Literature DB >> 29432084

The relationship between drug use settings, roles in the drug economy, and witnessing a drug overdose in Baltimore, Maryland.

Carl A Latkin1, Catie Edwards1, Melissa A Davey-Rothwell1, Cui Yang1, Karin E Tobin1.   

Abstract

BACKGROUND: There has been a dramatic increase in drug overdose deaths in the United States. In the current study, the authors examined factors associated with witnessing a drug overdose.
METHODS: A sample of 450 substance users in Baltimore, Maryland, were recruited for a behavioral intervention and were administered a survey. Multinomial logistic regression models were used to compare participants who never witnessed a drug overdose with those who witnessed one in the prior 6 months and those who witnessed an overdose over 6 months ago.
RESULTS: Most (58%) participants were male, 40% experienced homelessness in the prior 6 months, 63% reported a history of heroin injecting, 84% had snorted heroin, 75% reported witnessing a drug overdose, and 38% experienced an overdose. In multinomial logistic regression models, witnessing an overdose in the past 6 months was associated with number of different types of places where drugs were used (adjusted odds ratio [aOR] = 1.34), history of experiencing an overdose (aOR = 1.80), injecting heroin and/or speedball (aOR = 1.78), and snorting heroin (aOR = 1.54). Witnessing an overdose more than 6 months ago was associated with number of different places where drugs were used (aOR = 1.25), history of experiencing an overdose (aOR = 1.61), snorting heroin (aOR = 1.42), and injecting heroin or speedball (aOR = 1.47).
CONCLUSIONS: These data suggest that people who engage in more public and frequent drug use, and hence are more likely to witness an overdose, should be targeted for interventions to prevent and treat drug overdose.

Entities:  

Keywords:  Heroin; injection drug use; opioids; overdose; syringe exchange; witness

Mesh:

Year:  2018        PMID: 29432084      PMCID: PMC6107432          DOI: 10.1080/08897077.2018.1439801

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  19 in total

1.  Effect of abuse-deterrent formulation of OxyContin.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

2.  Fentanyl-laced street drugs "kill hundreds".

Authors:  David Boddiger
Journal:  Lancet       Date:  2006-08-12       Impact factor: 79.321

3.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

4.  Opioid Overdose Deaths in the City and County of San Francisco: Prevalence, Distribution, and Disparities.

Authors:  Adam J Visconti; Glenn-Milo Santos; Nikolas P Lemos; Catherine Burke; Phillip O Coffin
Journal:  J Urban Health       Date:  2015-08       Impact factor: 3.671

5.  Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.

Authors:  Theodore J Cicero; Matthew S Ellis
Journal:  JAMA Psychiatry       Date:  2015-05       Impact factor: 21.596

6.  Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.

Authors:  John Strang; Victoria Manning; Soraya Mayet; David Best; Emily Titherington; Laura Santana; Elizabeth Offor; Claudia Semmler
Journal:  Addiction       Date:  2008-10       Impact factor: 6.526

7.  Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol.

Authors:  Nina G Shah; Sarah L Lathrop; R Ross Reichard; Michael G Landen
Journal:  Addiction       Date:  2007-11-20       Impact factor: 6.526

8.  Overdoses among friends: drug users are willing to administer naloxone to others.

Authors:  Tara Lagu; Bradley J Anderson; Michael Stein
Journal:  J Subst Abuse Treat       Date:  2006-03

Review 9.  Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.

Authors:  Silvia S Martins; Laura Sampson; Magdalena Cerdá; Sandro Galea
Journal:  Am J Public Health       Date:  2015-11       Impact factor: 9.308

10.  Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics.

Authors:  Paul M Coplan; Hrishikesh Kale; Lauren Sandstrom; Craig Landau; Howard D Chilcoat
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-09-30       Impact factor: 2.890

View more
  8 in total

1.  Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.

Authors:  Tara Beaulieu; Kanna Hayashi; Ekaterina Nosova; M-J Milloy; Kora DeBeck; Evan Wood; Thomas Kerr; Lianping Ti
Journal:  Am J Drug Alcohol Abuse       Date:  2020-01-26       Impact factor: 3.829

2.  Stigma and drug use settings as correlates of self-reported, non-fatal overdose among people who use drugs in Baltimore, Maryland.

Authors:  Carl A Latkin; Rachel E Gicquelais; Catie Clyde; Lauren Dayton; Melissa Davey-Rothwell; Danielle German; Seun Falade-Nwulia; Haneefa Saleem; Michael Fingerhood; Karin Tobin
Journal:  Int J Drug Policy       Date:  2019-04-23

3.  The Geographic Distribution of Fentanyl-Involved Overdose Deaths in Cook County, Illinois.

Authors:  Elizabeth D Nesoff; Charles C Branas; Silvia S Martins
Journal:  Am J Public Health       Date:  2019-11-14       Impact factor: 9.308

4.  "I've been to more of my friends' funerals than I've been to my friends' weddings": Witnessing and responding to overdose in rural Northern New England.

Authors:  Kerry Nolte; Eric Romo; Thomas J Stopka; Aurora Drew; Patrick Dowd; Lizbeth Del Toro-Mejias; Elyse Bianchet; Peter D Friedmann
Journal:  J Rural Health       Date:  2022-03-17       Impact factor: 5.667

5.  Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.

Authors:  Saba Rouhani; Ju Nyeong Park; Kenneth B Morales; Traci C Green; Susan G Sherman
Journal:  Harm Reduct J       Date:  2019-06-24

6.  More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD.

Authors:  Lauren Dayton; Rachel E Gicquelais; Karin Tobin; Melissa Davey-Rothwell; Oluwaseun Falade-Nwulia; Xiangrong Kong; Michael Fingerhood; Abenaa A Jones; Carl Latkin
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.752

7.  Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: Data from the C3PNO Consortium.

Authors:  L King; K Hayashi; B Genberg; J Choi; K DeBeck; G Kirk; S H Mehta; M Kipke; R D Moore; M K Baum; S Shoptaw; P M Gorbach; B Mustanski; M Javanbakht; S Siminski; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2022-10-06       Impact factor: 4.852

8.  ``Now it is mostly done through stashes, to do it in person one has to trust you'': Understanding the retail injection drug market in Dnipro, Ukraine.

Authors:  Alyona Mazhnaya; Tetiana Kiriazova; Olena Chernova; Karin Tobin; Jill Owczarzak
Journal:  Int J Drug Policy       Date:  2020-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.